NCT02190123 - REalWorld Insights on the INitiation and Treatment Duration of ticagrEloR & Other Oral Antiplatelets (OAP) in Patients With Acute Coronary Syndrome (ACS) in Be/Lux. | Biotech Hunter

Enrollment

430

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions

Treatment of Acute Coronary Syndrome (ACS).

Interventions

DRUG

ACS patients treated with OAP

Patients with ACS who have been initiated and treated with ticagrelor and other oral antiplatelets.

Trial Locations (15)

Research Site, Aalst

Research Site, Baudour

Research Site, Bonheiden

Research Site, Brasschaat

Research Site, Bruges

Research Site, Brussels

Research Site, Charleroi

Research Site, Edegem

Research Site, Ghent

Research Site, Leuven

Research Site, Liège

Research Site, Mechelen

Research Site, Montegnée

Research Site, Ronse

Research Site, Uccle